SCHEMBL853346

SCHEMBL853346

CCCCCNc1nc(C)c(Cc2ccc(I)cc2)c(N)n1

nearest known ligand 0.47

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 12/20 0.47
TLR8 Q9NR97 4/20 0.46
SLC2A1 P11166 1/20 0.42
DHFR P00374 1/20 0.40
KCNH3 Q9ULD8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL854178 0.86 ALDH1A1 (0.51) TLR7TLR8SLC2A1DHFR
SCHEMBL853935 0.83 TLR7 (0.51) TLR7TLR8
SCHEMBL855086 0.82 DHFR (0.47) TLR7TLR8DHFR
SCHEMBL3706784 0.81 TLR8 (0.72) TLR7TLR8
SCHEMBL853213 0.80 TLR7 (0.57) TLR7TLR8DHFR
SCHEMBL860985 0.80 TLR7 (0.42) TLR7TLR8SLC2A1
SCHEMBL854804 0.80 TLR7 (0.55) TLR7TLR8DHFR
SCHEMBL853209 0.78 DHFR (0.59) TLR7TLR8DHFR
SCHEMBL853997 0.78 TLR7 (0.52) TLR7TLR8DHFR
SCHEMBL19056420 0.77 TLR7 (0.38) TLR7TLR8DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432768-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES AstraZeneca AB (SE) 2012-03-28 EP disclosed
WO-2010133885-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES ASTRAZENECA AB (SE) 2010-11-25 WO disclosed